Webinar

FDA: Embracing flexibility at the agency for advancing innovative therapies

In this fireside chat, “FDA: Embracing Flexibility at the Agency for Advancing Innovative Therapies,” our experts discuss the evolving landscape of regulatory frameworks at the FDA and how flexibility is crucial for the advancement of cell and gene therapies. They share insights on the importance of engaging with various stakeholders and the role of adaptive strategies in navigating the regulatory environment to bring innovative therapies to market. 

Explore how embracing flexibility and fostering collaboration with regulatory bodies can enhance the development and approval processes for innovative therapies, ultimately benefiting patients in need.

Speakers: 

  • Louis Cicchini - Director, Scientific Affairs, Cell & Gene Therapy at Cencora 
  • Celia Witten - Principal at Eliquent Life Sciences 

Fill out the form to watch the session

Pardot Form

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.
Abstract

Related resources

The portraits of two subject matter experts are contained in bubbles. Between them is a speech bubble icon.

Story | Expanding access globally

Table Talk: Beyond the breakthrough
Learn more

Article

The JCA unleashed: Key takeaways and outlook from early reports
Learn more

Webinar

Building HTA‑ready evidence with AI‑enabled early modeling
Learn more